Disparities in Uveal Melanoma: Patient Characteristics

REFERENCES

• Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1971997. Ophthalmology 2003;110 (5):956–961.
   PubMed Web of Science ®Google Scholar
• Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E. Incidence of uveal melanoma in Europe. Ophthalmology 2007;114(12):2309–2315.
   PubMed Web of Science ®Google Scholar
• Cerbone L, Van Ginderdeuren R, Van Den Oord J, Fieuws S, Spileers W, Van Eenoo L, Wozniak A, Sternberg CN, Schöffski P. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease. Oncology (Switzerland) 2014;86(3):185–189.
   PubMed Web of Science ®Google Scholar
• Singh AD, Turell ME, Topham AK. Uveal melanoma: Trends in incidence, treatment, and survival. Ophthalmology 2011;118(9):1881–1885.
   PubMed Web of Science ®Google Scholar
• Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology 2003;110(5): 962–965.
   PubMed Web of Science ®Google Scholar
• Bishop KD, Olszewski AJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: A population-based analysis. International Journal of Cancer 2014;134(12): 2961–2971.
   PubMed Web of Science ®Google Scholar
• Burr JM, Mitry E, Rachet B, Coleman MP. Survival from uveal melanoma in England and Wales 1986 to 2001. Ophthalmic Epidemiology 2007;14(1):3–8.
   PubMed Web of Science ®Google Scholar
• Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz J-M, Paci E. Survival in patients with uveal melanoma in Europe. Archives of Ophthalmology 2008;126(10): 1413–1418.
   PubMedGoogle Scholar
• Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Investigative Ophthalmology & Visual Science 2003;44(11):4651–4659.
   PubMed Web of Science ®Google Scholar
• Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B. Uveal melanoma survival in Sweden from 1960 to 1998. Investigative Ophthalmology and Visual Science 2003;44(8):3282–3287.
   PubMed Web of Science ®Google Scholar
• Mallone S, De Vries E, Guzzo M, Midena E, Verne J, Coebergh JW, Marcos-Gragera R, Ardanaz E, Martinez R, Chirlaque MD, Navarro C, Virgili G. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. European Journal of Cancer 2012;48 (8):1167–1175.
   PubMed Web of Science ®Google Scholar
• Hawkins BS, Collaborative Ocular Melanoma Study. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors, COMS report number 24. Am J Ophthalmol 2004;138 (6):936–51.
   Google Scholar
• Damato BE, Heimann H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma: Tentative evidence of a therapeutic effect on survival. JAMA Ophthalmology 2014;132(5):605–613.
   PubMed Web of Science ®Google Scholar
• Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. Journal of Clinical Oncology 2005;23(31):8076–8080.
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley La, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death advances in brief gene expression profiling in uveal melanoma reveals two molecular classes and predicts meta- static death. Cancer Research 2004;7205–7209.
   Google Scholar
• Chappell MC, Char DH, Cole TB, Harbour JW, Mishra K, Weinberg VK, Phillips TL. Uveal melanoma: Molecular pattern, clinical features, and radiation response. American Journal of Ophthalmology 2012;154(2):227–232.
   PubMed Web of Science ®Google Scholar
• McLaughlin CC, Wu X-C, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103(5):1000–7.
   Google Scholar
• Damato BE, Coupland SE. Differences in uveal melanomas between men and women from the British Islehs. Eye 2012;26 (2):292–299.
   PubMed Web of Science ®Google Scholar
• Zloto O, Pe’er J, Frenkel S. Gender differences in clinical presentation and prognosis of uveal melanoma. Investigative Ophthalmology & Visual Science 2013;54(1):652–6.
   PubMed Web of Science ®Google Scholar
• Caminal JM, Ribes J, Clèries R, Ibáñez N, Arias L, Piulats JM, Pera J, Gutierrez C, Arruga J. Relative survival of patients with uveal melanoma managed in a single center. Melanoma Research 2012;22(3):271–277.
   PubMed Web of Science ®Google Scholar
• Holly Ea, Aston Da, Ahn DK, Kristiansen JJ, Char DH. Uveal melanoma, hormonal and reproductive factors in women uveal melanoma, hormonal and reproductive factors in women. Cancer Research 1991;94305:1370–1372.
   Google Scholar
• Hartge P, Tucker MA, Shields JA, Augsburger J, Hoover RN, Fraumeni JF, Jr. Case-control study of female hormones and eye melanoma. Cancer Res 1989;49(16):4622–5.
   PubMed Web of Science ®Google Scholar
• Egan KM, Quinn JL, Gragoudas ES. Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol 1999;117(7):939–42.
   PubMedGoogle Scholar
• Schmidt-Pokrzywniak A, Kalbitz S, Kuss O, Jöckel K-H, Bornfeld N, Stang A. Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: A follow-up study. BMC Ophthalmology 2014;14(1):42–42.
   PubMed Web of Science ®Google Scholar
• Janerich DT. The fetal antigen hypothesis: Cancers and beyond. Med Hypotheses 2001;56(1):101–3.
   PubMed Web of Science ®Google Scholar
• Margo CE, Mulla Z, Billiris K. Incidence of surgically treated uveal melanoma by race and ethnicity. Ophthalmology 1998;105(6):1087–90.
   PubMed Web of Science ®Google Scholar
• Neugut AI, Kizelnik-Freilich S, Ackerman C. Black-White differences in risk for cutaneous, ocular, and visceral melanomas. American Journal of Public Health 1994;84 (11):1828–1829.
   PubMed Web of Science ®Google Scholar
• Hu D-N, Yu G-P, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. American Journal of Ophthalmology 2005;140(4):612–7.
   PubMed Web of Science ®Google Scholar
• Sun Hp LYPC. Iris color and associated pathological ocular complications: A review of epidemiologic studies. Int J Ophthalmol 2014;7(5):872–8.
   PubMed Web of Science ®Google Scholar
• Weis E, Shah CP, Lajous M, Shields JA, Shields CL. The association between host susceptibility factors and uveal melanoma: A meta-analysis. Arch Ophthalmol 2006;124(1):54–60.
   PubMedGoogle Scholar
• Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. International Journal of Cancer 2001;92(6):906–912.
   PubMed Web of Science ®Google Scholar
• van den Berg TJ, Jk IJ, de Waard PW. Dependence of intraocular straylight on pigmentation and light transmission through the ocular wall. Vision Res 1991;31(7–8):1361–7.
   PubMed Web of Science ®Google Scholar
• Menon IA, Wakeham DC, Persad SD, Avaria M, Trope GE, Basu PK. Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J Ocul Pharmacol 1992;8(1):35–42.
   PubMedGoogle Scholar
• Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999;340(17):1341–8.
   PubMed Web of Science ®Google Scholar
• Elwood JM, Jopson J. Melanoma and sun exposure: An overview of published studies. Int J Cancer 1997;73(2):198–203.
   PubMed Web of Science ®Google Scholar
• Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004;49(4):419–28.
   PubMed Web of Science ®Google Scholar
• Mallet JD, Gendron SP, Drigeard Desgarnier MC, Rochette PJ. Implication of ultraviolet light in the etiology of uveal melanoma: A review. Photochem Photobiol 2013: 90(1):15–21.
   Web of Science ®Google Scholar
• Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res 2000;60(14):3757–60.
   PubMed Web of Science ®Google Scholar
• Schwartz LH, Ferrand R, Boelle PY, Maylin C, D'Hermies F, Virmont J. Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution. Radiat Res 1997;147(4):451–6.
   PubMed Web of Science ®Google Scholar
• Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12(5):552–7.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken JF, Giles GG, Armstrong BK. Artificial ultraviolet radiation and ocular melanoma in Australia. Int J Cancer 2004;112(5):896–900.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002;101(2):175–82.
   PubMed Web of Science ®Google Scholar
• Horn EP, Hartge P, Shields JA, Tucker MA. Sunlight and risk of uveal melanoma. J Natl Cancer Inst 1994;86(19):1476–8.
   PubMedGoogle Scholar
• Guenel P, Laforest L, Cyr D, Fevotte J, Sabroe S, Dufour C, Lutz JM, Lynge E. Occupational risk factors, ultraviolet radiation, and ocular melanoma: A case-control study in France. Cancer Causes Control 2001;12(5):451–9.
   PubMed Web of Science ®Google Scholar
• Tucker MA, Shields JA, Hartge P, Augsburger J, Hoover RN, Fraumeni JF, Jr. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985;313 (13):789–92.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma: A case-control study. Arch Ophthalmol 1990;108(9):1274–80.
   PubMedGoogle Scholar
• Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990;50 (18):5773–7.
   PubMed Web of Science ®Google Scholar
• Shah CP, Weis E, Lajous M, Shields Ja, Shields CL. Intermittent and chronic ultraviolet light exposure and uveal melanoma: A meta-analysis. Ophthalmology 2005;112(9):1599–1607.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Brantley MA, Jr., Hollingsworth H, Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol 2004;88(1):39–43.
   PubMed Web of Science ®Google Scholar
• Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: Is this relevant to malignant melanoma? Br J Dermatol 2002;147(2):197–213.
   PubMed Web of Science ®Google Scholar
• Burns EM, Elmets CA, Yusuf N. Vitamin D and skin cancer. Photochem Photobiol 2015;91(1):201–9.
   PubMed Web of Science ®Google Scholar
• Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13(9):1502–8.
   PubMed Web of Science ®Google Scholar
• John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: The NHANES I Epidemiologic follow-up study, 1971–1975 to 1992: National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999; 8 (5):399–406.
   PubMed Web of Science ®Google Scholar
• Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004;15(2):149–58.
   PubMed Web of Science ®Google Scholar
• Yu GP, Hu DN, McCormick SA. Latitude and incidence of ocular melanoma. Photochem Photobiol 2006;82(6):1621–6.
   PubMed Web of Science ®Google Scholar
• Swerdlow AJ. Epidemiology of eye cancer in adults in England and Wales, 1962–1977. Am J Epidemiol 1983;118 (2):294–300.
   PubMed Web of Science ®Google Scholar
• Schmidt-Pokrzywniak A, Jockel KH, Marr A, Bornfeld N, Stang A. A case-control study: Occupational cooking and the risk of uveal melanoma. BMC Ophthalmol 2010;10:26.
   PubMed Web of Science ®Google Scholar
• Jay M, McCartney AC. Familial malignant melanoma of the uvea and p53: A Victorian detective story. Surv Ophthalmol 1993;37(6):457–62.
   PubMed Web of Science ®Google Scholar
• Silcock AQ. Hereditary sarcoma of the eyeball. Trans Pathol Soc Lond 1892;43:140–141.
   Google Scholar
• Singh AD, Shields CL, De Potter P, Shields JA, Trock B, Cater J, Pastore D. Familial uveal melanoma: Clinical observations on 56 patients. Arch Ophthalmol 1996;114(4):392–9.
   PubMedGoogle Scholar
• Klebe S, Driml J, Nasu M, Pastorino S, Zangiabadi A, Henderson D, Carbone M. BAP1 hereditary cancer predisposition syndrome: A case report and review of literature. Biomark Res 2015;3:14.
   Google Scholar
• Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011;43(10):1022–5.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330(6009):1410–3.
   PubMed Web of Science ®Google Scholar
• Gonder JR, Shields JA, Albert DM, Augsburger JJ, Lavin PT. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology 1982;89(8):953–60.
   PubMed Web of Science ®Google Scholar
• Gonder JR, Ezell PC, Shields JA, Augsburger JJ. Ocular melanocytosis: A study to determine the prevalence rate of ocular melanocytosis. Ophthalmology 1982;89(8):950–2.
   PubMed Web of Science ®Google Scholar
• Shields CL, Kaliki S, Livesey M, Walker B, Garoon R, Bucci M, Feinstein E, Pesch A, Gonzalez C, Lally SE, Mashayekhi A, Shields JA. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: Analysis of 7872 consecutive eyes. JAMA Ophthalmol 2013;131(8):993–1003.
   PubMed Web of Science ®Google Scholar
• Weis E, Shah CP, Lajous M, Shields JA, Shields CL. The association of cutaneous and iris nevi with uveal melanoma: A meta-analysis. Ophthalmology 2009;116 (3):536–543 e2.
   PubMed Web of Science ®Google Scholar
• Houlston RS, Damato BE. Genetic predisposition to ocular melanoma. Eye (London, England) 1999;13 ( Pt 1) (June):43–46.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Sains RS. Ocular findings in patients with dysplastic nevus syndrome: An update. Dermatol Clin 1991;9 (4):723–8.
   PubMed Web of Science ®Google Scholar
• van Hees CL, Jager MJ, Bleeker JC, Kemme H, Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res 1998;8(2): 175–80.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma: A case-control study. Archives of Ophthalmology 1990;108(9):1274–1280.
   PubMedGoogle Scholar
• Johnson MW, Skuta GL, Kincaid MC, Nelson CC, Wolter JR. Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol 1989;107 (3):402–7.
   PubMedGoogle Scholar